SUNNIFORECAST - A phase II study of Nivolumab in combination with
Ipilimumab versus Standard of care in advanced or metastatic non-clear
cell renal cell carcinoma
Dokumenttyp:
Meeting Abstract
Autor(en):
Scheich, S.; Ahrens, M.; Goekbuget, N.; Boleti, E.; Burkholder, I; Escudier, B. J.; Goebell, P. J.; Gruenwald, V; Gschwend, J.; Retz, M.; Hartmann, A.; Maroto Rey, J. P.; Miller, K.; Grimm, M. -O; Siemer, S.; Panic, A.; Bergmann, L.